ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Cancer Research|2012Cited by 131
Data from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Tables 1-6 from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Figures 1-10 from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0
Supplementary Methods and Materials from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and InvasionJulie A. Vendrell, Pascale A. Cohen, Aurélie Thollet et al.|Unknown|2023Cited by 0